Mode VC

Gareth King

Life Science Partner, GM&C Life Sciences Fund atCatapult VenturesFirm active Oct 13Manchester
LinkedIn Catapult Ventures websiteFirm profile

Dr Gareth King is a Life Science Partner at Catapult Ventures' GM&C Life Sciences Fund, leading investments since late 2015. He was previously CEO of Critical Pharmaceuticals and has held roles at Pharmaceutical Profiles, Cyprotex, AstraZeneca, and Incyte.

What Gareth can write

Writes checks of$250K to $3MEstimate
Comes in atSeed, Series ALead preference not reported
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Catapult Ventures writes $250K to $3M checks, larger than 33% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Catapult Ventures.

Career

  1. Harvard Medical School · Research Fellow
  2. AstraZeneca · Bioinformatics Project Manager
  3. Incyte
  4. Cyprotex · Commercial Director
  5. Pharmaceutical Profiles · VP Business Development
  6. Critical Pharmaceuticals · CEO
  7. Catapult Ventures · Investment Manager
    Now
  8. Catapult Ventures · Life Science Partner
    Now

Focus

life sciencesbiotechpharmadigital healthcare

Education

Sheffield University, BSc in MicrobiologyEdinburgh University, PhD in Molecular Genetics

Also at Catapult Ventures

Darren LiccardoCofounder and Managing Director
Rouz JazayeriCo-Founder and Managing Director
Rob CarrollManaging Director

Partners like Gareth

At firms with a similar stage, sector and check size.

Dan Kerr
Dan KerrManaging Partner, Flyover Capital
Joanna Drake
Joanna DrakeCo-Founder & Managing Partner, Magnify Ventures
Andy Will
Andy WillGeneral Partner, Motivate Venture Capital
Paul Lacerte
Paul LacerteChief Purpose Officer, Raven Indigenous Capital Partners
John Stokes
John StokesManaging Partner, Real Ventures
Lan Xuezhao
Lan XuezhaoFounder & Managing Partner, Basis Set Ventures

Alert me when Catapult Ventures is active

One email when Gareth's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Gareth King?

Dr Gareth King is a Life Science Partner at Catapult Ventures' GM&C Life Sciences Fund, leading investments since late 2015. He was previously CEO of Critical Pharmaceuticals and has held roles at Pharmaceutical Profiles, Cyprotex, AstraZeneca, and Incyte.

How much does Gareth King invest?

Gareth King invests through Catapult Ventures, which writes checks of $250K to $3M at seed, series a.

How do I pitch Gareth King?

A warm intro from a founder Catapult Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.

What did Gareth King do before Catapult Ventures?

Research Fellow at Harvard Medical School; Bioinformatics Project Manager at AstraZeneca; Incyte; Commercial Director at Cyprotex; VP Business Development at Pharmaceutical Profiles; CEO at Critical Pharmaceuticals.

Last updated 2026-10-15. Is this you? Ask for a correction.